On 30 May, EUCOPE – the European Confederation of Pharmaceutical Entrepreneurs hosted the inaugural episode of its Life Science Lectures webinar series, “Attaching conditionalities to incentives: the right path to improve access?” The episode delved into the incentive system outlined in the EU Pharmaceutical Package,… read more
In October 2022, EUCOPE joined a large group of European stakeholders to welcome the European Commission’s proposal on the European Health Data Space (EHDS), and to highlight common recommendations. We share the view that health data are precious and renewable resources that can power decision-making… read more
Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In May, we spoke with Gerwin Winter, Senior Vice President – Head of Europe at BeiGene. Gerwin Winter joined BeiGene… read more
On Friday, 5 May, the WHO Director General declared an end to the Public Health Emergency of International Concern (PHEIC) for the disease caused by the coronavirus SARS-CoV-2. COVID-19 was declared a PHEIC on 30 January 2020. For more than three years, the pandemic wreaked… read more
On 4 May 2023, EUCOPE was announced as a member of the Health Technology Assessment (HTA) Stakeholder Network. The Network has been established to facilitate contributions by a wide range of stakeholders to policy development related to HTAs in the European Union (EU). Since its… read more
EUCOPE joined an industry coalition to warn of the potential conflicts between the Data Act and the GDPR, emphasising the importance of ensuring a fair playing field. The letter, sent to several Members of the European Parliament, the Swedish Presidency, and Commissioner Mr. Breton, warns of… read more
In legislation put forward today, the Commission has proposed introducing a pan-EU compulsory license that could apply to products such as essential drugs in a future pandemic. The European Commission published proposals to introduce a Union compulsory license for crises management and an EU-wide unitary… read more
On the Commission’s proposal for the EU Pharmaceutical Package On 26 April, the European Commission published the EU Pharmaceutical Package, revising how the pharmaceutical system is regulated in the EU, which includes a proposal for a “master” Regulation, merging Commission Regulation No 726/2004, Orphan Medicinal… read more
Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In March, we spoke with Fabien Roy, Partner, Hogan Lovells Life Sciences practice. Fabien Roy is a partner at Hogan… read more
In November 2020, the European Commission adopted the EU Pharmaceutical Strategy, aimed at creating a future-proof regulatory framework and at supporting the industry in promoting research and technologies that reach patients in order to fulfil their therapeutic needs while addressing market failures. As part of… read more
Keep up-to-date on all of the most pertinent policy files and regulatory news around the world of European health technologies with our monthly newsletter – the Innovation Eye-View
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
You are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
You are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.